HONG KONG, Feb. 22, 2011 /PRNewswire-Asia-FirstCall/ --
China Cord Blood Corporation (NYSE: CO) ("CCBC" or "the Company"),
the first and largest cord blood banking operator in China, today announced the results of its 2010
Annual General Meeting, which was held on February 18, 2011, in Hong Kong.
At the Annual General Meeting, shareholders
- elected Albert Chen and
Mark Chen to serve on the Board of
Directors until the 2013 annual general meeting of the Company or
until their respective successors are duly appointed and
qualified;
- ratified the appointment of KPMG as auditor of the Company for
the financial year ending March 31,
2011, and authorized the directors to set the remuneration
of the auditors; and
- adopted the 2011 China Cord Blood Corporation Restricted Share
Unit Scheme, or the "Incentive Plan," which has a mandate limit of
granting rights to receive ordinary shares not exceeding 10.0% of
the Company's issued and outstanding share capital, to directors,
officers, employees and/or consultants of the Company and its
subsidiaries and authorize directors to grant awards and allot and
issue shares thereunder.
About China Cord Blood Corporation
China Cord Blood Corporation is the first and largest cord blood
banking operator in China in terms
of geographical coverage and is the only cord blood banking
operator with multiple licenses. Under the current PRC government
regulations, only one licensed cord blood banking operator is
permitted to operate in each licensed region and only seven
licenses have been authorized as of today. China Cord Blood
Corporation provides cord blood collection, laboratory testing,
hematopoietic stem cell processing, and stem cell storage services.
For more information, please visit our website at
http://www.chinacordbloodcorp.com.
For more information, please
contact:
|
|
|
|
China Cord Blood
Corporation
|
|
Ms. Joeling Law
|
|
Tel:
+852-3605-8180
|
|
Email:
ir@chinacordbloodcorp.com
|
|
|
|
ICR, LLC
|
|
In New York:
|
|
Ashley M. Ammon
|
|
Tel: +1-646-277-1227
|
|
|
|
In Beijing:
|
|
Wen Lei Zheng
|
|
Tel: +86-10-6583-7510
|
|
|
SOURCE China Cord Blood Corporation